Skip to main content
TASCOM Co.,Ltd. logo

TASCOM Co.,Ltd. — Investor Relations & Filings

Ticker · 336040 ISIN · KR7336040001 KO Manufacturing
Open in API
Filings indexed 189 across all filing types
Latest filing 2024-04-26 AGM Information
Country KR South Korea
Listing KO 336040

About TASCOM Co.,Ltd.

http://tascom.org/

TASCOM Co., Ltd. is a company that develops, manufactures, and distributes medical devices, specializing in in vitro diagnostics (IVD) and diabetes management. Its key product is the SimplexTAS series, a point-of-care testing (POCT) immunochemistry system that functions as a portable analyzer for quantitative, multi-parameter biochemical immunoassays using small blood or urine samples. The company's portfolio also includes a range of diabetic supplies, such as blood glucose measurement systems and insulin syringes. Additionally, TASCOM is engaged in the research and development of cell therapy products.

Recent filings

Filing Released Lang Actions
주주총회소집공고
AGM Information Classification · 1% confidence The document is a formal 'Notice of Extraordinary General Meeting' (임시주주총회 소집공고) for a company named Tascom. It includes the meeting agenda (election of directors, discontinuation of research projects), procedural details for shareholders, and a comprehensive 'Management Report' (경영참고사항) section detailing business operations, industry analysis, and market outlook. While it contains management information, the primary purpose of the document is to formally convene a shareholder meeting, which falls under the category of Proxy Solicitation & Information Statement (PSI) as it provides the necessary information for shareholders to vote on the proposed agenda items.
2024-04-26 Korean
[기재정정]주주총회소집결의
AGM Information Classification · 1% confidence The document is a formal notice regarding the convocation of an Extraordinary General Meeting (EGM) and a correction to a previously filed notice. It details the agenda items, specifically the appointment of directors and the discontinuation of a research project. This type of document, which provides information to shareholders regarding upcoming meeting agendas and voting items, is classified as Proxy Solicitation & Information Statement (PSI) as it serves to inform shareholders of the matters to be voted upon.
2024-04-26 Korean
[기재정정]주주총회소집공고
AGM Information Classification · 1% confidence The document is a formal 'Notice of Extraordinary General Meeting' (임시주주총회 소집통지서) issued by Tascom. It includes the meeting agenda, date, location, and management reference materials (경영참고사항) regarding the company's business operations and industry outlook. This document is a standard proxy solicitation and information statement provided to shareholders to inform them of the meeting and the items to be voted upon.
2024-04-26 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a formal announcement regarding the scheduling and logistics of an upcoming Investor Relations (IR) meeting (기업설명회). It provides the date, time, location, target audience, and purpose of the event. Since it is an announcement of an event rather than the presentation materials themselves, and it does not fit into specific categories like 'Call Transcript' or 'Annual Report', it falls under the general regulatory announcement category for corporate events.
2024-04-24 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 1% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure period for an upcoming Extraordinary General Meeting (EGM). It does not contain the full proxy materials or the meeting presentation itself, but rather serves as a formal regulatory notice of the procedural steps for the meeting. Given it is a specific regulatory announcement regarding corporate governance procedures, it fits best under the RNS category.
2024-03-29 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled '정기주주총회 결과' (Regular General Meeting of Shareholders Results) and provides the official outcomes of the meeting held on 2024-03-28, including the approval of financial statements, director/auditor compensation limits, and dividend status. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2024-03-28 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.